Constrictive pericarditis after SARS-CoV-2 vaccination: A case report

Int J Infect Dis. 2022 Mar:116:238-240. doi: 10.1016/j.ijid.2022.01.027. Epub 2022 Jan 19.

Abstract

Coronavirus disease 2019 (COVID-19) and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are associated with cardiovascular complications. Here, we report a case of right-sided heart failure caused by constrictive pericarditis that developed after the administration of messenger ribonucleic acid (mRNA) vaccine against SARS-CoV-2. A 70-year-old woman presented with body weight gain, peripheral edema, and dyspnea on effort, which developed over a period of 1 week after the second dose of vaccine. The jugular venous pressure was high with a prominent y descent (Friedreich's sign) and paradoxical increase on inspiration (Kussmaul's sign). The results of IgM and IgG testing specific to SARS-CoV-2 spike and nucleocapsid proteins indicated the presence of mRNA vaccine-induced antibody and were not suggestive of COVID-19 infection. Echocardiography showed pericardial thickening and septal bounce of the interventricular septum. Computed tomography (CT) also showed pericardial thickening compared with the results of the previous CT scan performed 4 months earlier. A diagnosis of right-sided heart failure due to constrictive pericarditis was confirmed on the basis of pressure analysis during cardiac catheterization.

Keywords: COVID-19; Constrictive pericarditis; SARS-CoV-2; Vaccination.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Female
  • Humans
  • Pericarditis, Constrictive* / complications
  • Pericarditis, Constrictive* / etiology
  • SARS-CoV-2
  • Vaccination / adverse effects
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccines